Sunitinib (Sutent) for Kidney Cancer
Links shared publicly online about this topic
Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer - Drugs.com MedNews
drugs.com — “The oral cancer drug sunitinib (Sutent) has shown promising results in advanced kidney cancer patients who have a poor prognosis, new research says. Previous cl” View full resource at drugs.com
Most Recently Shared on July 16, 2009 at 7:56 pm By:
Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer - http://bit.ly/iA1EV
Sutent Approved for Rare Pancreatic Cancer
health.yahoo.net — “MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body.” View full resource at health.yahoo.net
Most Recently Shared on May 23, 2011 at 5:19 pm By:
allergydropz Surgeon, ENT Doctor, Physician, and Doctor
Yahoo health: Sutent Approved for Rare Pancreatic Cancer http://bit.ly/lrohqJ Full http://bit.ly/lP8e3J
Sutent Approved for Rare Pancreatic Cancer
health.yahoo.net — “MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body.” View full resource at health.yahoo.net
Most Recently Shared on May 24, 2011 at 12:49 am By:
Jennifer Ann Grisso Nurse and Active Health Library
Sutent Approved for Rare Pancreatic Cancer: MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administratio... http://bit.ly/jHoEuw
Medical News: Sunitinib Active in Poor-Prognosis Kidney Cancer - in Oncology, Other Cancers from MedPage Today
medpagetoday.com — “HOUSTON -- Patients with poor-prognosis renal cell carcinoma had an encouraging response to sunitinib (Sutent) without undue toxicity, investigators in an international clinical trial reported.” View full resource at medpagetoday.com
Most Recently Shared on July 16, 2009 at 2:47 pm By:
Sunitinib Active in Poor-Prognosis Kidney Cancer (CME/CE) http://bit.ly/Glfl2
FDA Approves Sutent for Pancreatic Cancer
onclive.com — “The FDA has approved Sutent (sunitinib) for the treatment of patients with unresectable, locally advanced, or metastatic pancreatic neuroendocrine tumors (pNET)” View full resource at onclive.com
Most Recently Shared on May 23, 2011 at 9:54 pm By:
The FDA has approved Sutent (sunitinib) for unresectable pancreatic neuroendocrine tumors (pNET) http://goo.gl/MnX17
Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer
health.msn.com — “Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer” View full resource at health.msn.com
Most Recently Shared on July 16, 2009 at 1:36 pm By:
Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer http://bit.ly/Lg5qW
Afinitor approved in US as first treatment for patients with advanced kidney cancer after failure of either sunitinib or sorafenib
novartis.com — “Basel, March 30, 2009 - Novartis announced today that Afinitor (everolimus) tablets has been approved by the US Food and Drug Administration (FDA) for patients with advanced renal cell carcinoma (RCC) after failure of treatment with Sutent (sunitinib)* or Nexavar (sorafenib)**.” View full resource at novartis.com
Most Recently Shared on March 30, 2009 at 7:53 pm By:
Afinitor® approved in US as first treatment for patients with advanced kidney cancer after failure of either sun.. http://twurl.nl/kwsasn
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 7:16 am By:
FDA Approves Sutent for Rare Type of Pancreatic Cancer - http://bit.ly/j6v3Lp
FDA Approves Sutent for Rare Type of Pancreatic Cancer
drugs.com — “Sutent (sunitinib) is used to treat pancreatic neuroendocrine tumors. Includes Sutent side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 8:13 am By:
Drugs and Devices OW OW Health
FDA Approves Sutent for Rare Type of Pancreatic Cancer: SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNew... http://bit.ly/lGiA67 #drug
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 8:06 am By:
MNT Drug Approvals Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3Wc7 #regulatory
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 7:06 am By:
MNT Pancreatic Can Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3WmW #pancreaticcancer
SUTENT(R) (Sunitinib) Receives European Approval For A New Indication In Progressive Pancreatic Neuroendocrine Tumours (NET)
medicalnewstoday.com — “Pfizer Ltd announced that the European Commission has approved SUTENT® (sunitinib malate) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours” View full resource at medicalnewstoday.com
Most Recently Shared on December 16, 2010 at 1:05 pm By:
SUTENT(R) (Sunitinib) Receives European Approval For A New Indication In Progressive Pancreatic Neuroendocrine Tumours... http://mnt.to/3P4R
Sutent for Rare Type of Pancreatic Cancer Approved by FDA
disabled-world.com — “Sutent (sunitinib) approved for progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or have spread to other parts of the body” View full resource at disabled-world.com
Most Recently Shared on May 22, 2011 at 9:21 pm By:
Disabled World Health Advocate and Health News
Sutent for Rare Type of Pancreatic Cancer Approved by FDA http://ff.im/-DWIfW
Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer - myOptumHealth
myoptumhealth.com — “Read the news article Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on July 16, 2009 at 7:40 pm By:
myOptumHealth: Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer: Treatment safe in advan.. http://cli.gs/j6W0V
Pancreatic Cancer Drugs Sutent And Afinitor Recommended By FDA Advisory Committee
medicalnewstoday.com — “Sutent (sunitinib malate) and Afinitor (everolimus) were recommended for approval for the treatment of unresectable pancreatic neuroendocrine tumors, a rare type of pancreatic cancer - by the FD” View full resource at medicalnewstoday.com
Most Recently Shared on April 13, 2011 at 5:05 pm By:
MNT Drug Approvals Health News
Pancreatic Cancer Drugs Sutent And Afinitor Recommended By FDA Advisory Committee http://mnt.to/3TBz #regulatory
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
allergydropz
Nashville's allergy experts. Allergycare of Cool Springs is pleased to offer a new, exciting and innovative allergy treatment that doesnt require shots!
-
Jennifer Ann Grisso
Jennifer, RN,BSN Business Minded RN, Over 20 years as an RN in most areas.Chicagoan !Great sense of humor. Learning and studying HIT. Sold Medical Supplies and Devices. Nursing experience in most areas, more in Cardiac.
Advertisement
